Search Results - "Phillips, P. J"

A prospective diffusion tensor imaging study in mild traumatic brain injury by MAYER, A. R, LING, J, MANNELL, M. V, GASPAROVIC, C, PHILLIPS, J. P, DOEZEMA, D, REICHARD, R, YEO, R. A

“…Only a handful of studies have investigated the nature, functional significance, and course of white matter abnormalities associated with mild traumatic brain…”
Get full text

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis by Gillespie, Stephen H, Crook, Angela M, McHugh, Timothy D, Mendel, Carl M, Meredith, Sarah K, Murray, Stephen R, Pappas, Frances, Phillips, Patrick P.J, Nunn, Andrew J

“…One approach to improving tuberculosis therapy is to shorten the duration from 6 months to 4 months. In this trial in over 1900 patients with smear-positive…”
Get full text

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis by Jindani, Amina, Harrison, Thomas S, Nunn, Andrew J, Phillips, Patrick P.J, Churchyard, Gavin J, Charalambous, Salome, Hatherill, Mark, Geldenhuys, Hennie, McIlleron, Helen M, Zvada, Simbarashe P, Mungofa, Stanley, Shah, Nasir A, Zizhou, Simukai, Magweta, Lloyd, Shepherd, James, Nyirenda, Sambayawo, van Dijk, Janneke H, Clouting, Heather E, Coleman, David, Bateson, Anna L.E, McHugh, Timothy D, Butcher, Philip D, Mitchison, Denny A

“…In this report from sub-Saharan Africa, a 4-month regimen of moxifloxacin and rifapentine for pulmonary tuberculosis was not as beneficial as two 6-month…”
Get full text

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse by Phillips, Patrick P J, Fielding, Katherine, Nunn, Andrew J

“…It is widely acknowledged that new regimens are urgently needed for the treatment of tuberculosis. The primary endpoint in the Phase III trials is a composite…”
Get full text

Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial by Weir, Isabelle R, Dufault, Suzanne M, Phillips, Patrick P J

“…Randomized trials for the treatment of tuberculosis (TB) rely on a composite primary outcome to capture unfavorable treatment responses. However, variability…”
Get full text

High-temperature deformation mechanisms in a polycrystalline nickel-base superalloy studied by neutron diffraction and electron microscopy by Francis, E.M., Grant, B.M.B., Fonseca, J. Quinta da, Phillips, P.J., Mills, M.J., Daymond, M.R., Preuss, M.

“…To study the effect of γ′ precipitate size on the deformation behaviour of a polycrystalline nickel-based superalloy, model microstructures with a unimodal γ′…”
Get full text

A comparison of clinical development pathways to advance tuberculosis regimen development by Chang, V, Phillips, P P J, Imperial, M Z, Nahid, P, Savic, R M

“…Current tuberculosis (TB) regimen development pathways are slow and in urgent need of innovation. We investigated novel phase IIc and seamless phase II/III…”
Get full text

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials by Hills, N K, Lyimo, J, Nahid, P, Savic, R M, Lienhardt, C, Phillips, P P J

“…Safe, more efficacious treatments are needed to address the considerable morbidity and mortality associated with pulmonary tuberculosis (TB). However, the…”
Get full text

Functional connectivity in the developing brain: A longitudinal study from 4 to 9 months of age by DAMARAJU, E, CAPRIHAN, A, LOWE, J. R, ALLEN, E. A, CALHOUN, V. D, PHILLIPS, J. P

“…We characterize the development of intrinsic connectivity networks (ICNs) from 4 to 9 months of age with resting state magnetic resonance imaging performed on…”
Get full text

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial by Semitala, Fred C, Kadota, Jillian L, Musinguzi, Allan, Nabunje, Juliet, Welishe, Fred, Nakitende, Anne, Akello, Lydia, Bishop, Opira, Patel, Devika, Sammann, Amanda, Nahid, Payam, Belknap, Robert, Kamya, Moses R, Handley, Margaret A, Phillips, Patrick P J, Katahoire, Anne, Berger, Christopher A, Kiwanuka, Noah, Katamba, Achilles, Dowdy, David W, Cattamanchi, Adithya

“…Scaling up shorter regimens for tuberculosis (TB) prevention such as once weekly isoniazid-rifapentine (3HP) taken for 3 months is a key priority for achieving…”
Get full text

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial by Phillips, P P J, Van Deun, A, Ahmed, S, Goodall, R L, Meredith, S K, Conradie, F, Chiang, C-Y, Rusen, I D, Nunn, A J

“…The STREAM trial demonstrated that a 9-11-month "short" regimen had non-inferior efficacy and comparable safety to a 20+ month "long" regimen for the treatment…”
Get full text

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial by Witney, Adam A, Bateson, Anna L E, Jindani, Amina, Phillips, Patrick P J, Coleman, David, Stoker, Neil G, Butcher, Philip D, McHugh, Timothy D

“…RIFAQUIN was a tuberculosis chemotherapy trial in southern Africa including regimens with high-dose rifapentine with moxifloxacin. Here, the application of…”
Get full text

Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation by Bogdanova, E N, Mariandyshev, A O, Balantcev, G A, Eliseev, P I, Nikishova, E I, Gaida, A I, Enarson, D, Detjen, A, Dacombe, R, Phillips, P P J, Squire, S B, Gospodarevskaya, E

“…The development of new diagnostic tools allows for faster detection of both tuberculosis (TB) and multidrug-resistant (MDR) TB and should lead to reduced…”
Get full text

Principles for designing future regimens for multidrug-resistant tuberculosis by BRIGDEN, Grania, NYANG'WA, Bern-Thomas, PHILLIPS, Patrick P. J, BALASEGARAM, Manica, DU CROS, Philipp, VARAINE, Francis, HUGHES, Jennifer, RICH, Michael, HORSBURGH, C. Robert, MITNICK, Carole D, NUERMBERGER, Eric, MCILLERON, Helen

“…Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes…”
Get full text

2MASS near-infrared photometry of symbiotic stars by Phillips, J. P.

“…We present Two Micron All Sky Survey photometry for 216 symbiotic and possible symbiotic stars. This represents the most comprehensive near-infrared photometry…”
Get full text

Setting Tuberculosis Regimen Development on a Firm Foundation by Phillips, Patrick P J

Get full text

The effect of vascular changes on the photoplethysmographic signal at different hand elevations by Hickey, M, Phillips, J P, Kyriacou, P A

“…In order to further understand the contribution of venous and arterial effects to the photoplethysmographic (PPG) signal, recordings were made from 20 healthy…”
Get more information

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment by HONEYBORNE, Isobella, MCHUGH, Timothy D, WALZL, Gerhard, GILLESPIE, Stephen H, PHILLIPS, Patrick P. J, BANNOO, Selina, BATESON, Anna, CARROLL, Nora, PERRIN, Felicity M, RONACHER, Katharina, WRIGHT, Laura, VAN HELDEN, Paul D

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Performance comparison of Yb:YAG ceramics and crystal gain material in a large-area, high-energy, high average-power diode-pumped laser by Divoky, M, Pilar, J, Hanus, M, Navratil, P, Sawicka-Chyla, M, De Vido, M, Phillips, P J, Ertel, K, Butcher, T, Fibrich, M, Green, J T, Koselja, M, Preclikova, J, Kubat, J, Houzvicka, J, Rus, B, Collier, J, Lucianetti, A, Mocek, T

“…We compare for the first time the influence of different Yb:YAG gain media on the performance of a large-area, high average-power laser system with an output…”
Get full text

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia by Eliseev, Platon, Balantcev, Grigory, Nikishova, Elena, Gaida, Anastasia, Bogdanova, Elena, Enarson, Donald, Ornstein, Tara, Detjen, Anne, Dacombe, Russell, Gospodarevskaya, Elena, Phillips, Patrick P J, Mann, Gillian, Squire, Stephen Bertel, Mariandyshev, Andrei

“…In the Arkhangelsk region of Northern Russia, multidrug-resistant (MDR) tuberculosis (TB) rates in new cases are amongst the highest in the world. In 2014,…”
Get full text